Personalised medicine: a political priority
Precision cancer medicine is challenging politicians, health authorities, industry and patient organisations to think new about current meth
top of page
Norwegian Cancer Precision Medicine Implementation Consortium
Nyheter
Apr 162 min read
Ny prosjektleder i CONNECT
Andreas Høiaas er den nye prosjektlederen i CONNECT. Han kombinerer den nye rollen med jobben som politisk rådgiver hos Kreftforeningen....
Feb 273 min read
Ny styreleder i CONNECT
Hege Edvardsen fra GSK tar over som styreleder fra helseindustriens side i konsortiet CONNECT. – For meg som styreleder blir det...
Jan 293 min read
This is INSPIRE-BIO
This new sub project of CONNECT aims to establish a better transfer of structured data for molecular analyses from pathology in the...
Dec 13, 20233 min read
CONNECT highlights in 2023
The year began with a new strategy for personalised medicine in Norway, marking a flying start for CONNECT. The consortium has hosted a...
Sep 19, 20231 min read
Hva er persontilpasset medisin?
En kort film som forklarer persontilpasset medisin: å gi rett medisin til rett person til rett tid.
Sep 14, 20232 min read
GSK enters IMPRESS Norway
Two precision medicine drugs from CONNECT partner GSK are the newest additions to the clinical trial IMPRESS.
Aug 21, 20233 min read
Personalised medicine to relieve the health service
Smaller patient groups and targeted treatments are the future of cancer care in Norway.
May 2, 20233 min read
Advancing precision cancer medicine via European collaboration
Learn more about the EU-funded Norwegian initiatives PCM4EU and PRIME-ROSE, and the Norwegian MATRIX Centre.
bottom of page